Pharmacology conferences

PharmSci 360 connects experimental, computational and clinical evidence across drug discovery, development and delivery. Researchers will examine in-vitro-to-human translation using PBPK, quantitative systems pharmacology and AI; organ-chip and other human-relevant models; biomarkers and reliable bioanalytical assays; and integrating clinical trials with real-world data. Manufacturing sessions connect process understanding, analytical characterization and digital models with quality and scale-up. Formulation sessions address predictive design, advanced materials, targeted delivery and patient usability, alongside career development. Programme participants include Julie L. Gerberding (Foundation for the National Institutes of Health (FNIH)); Stephanie Barrett (Merck & Co., Inc.); Ben Boyd (Monash Institute of Pharmaceutical Sciences); Stephan Schmidt (University of Florida); Douglas Kiehl (Purdue University); Samir Mitragotri (Harvard University); Eric Appel (Stanford University). The American Association of Pharmaceutical Scientists hosts this in-person meeting at the Ernest N. Morial Convention Center, New Orleans, on 25–28 October 2026. The opening plenary is 25 October, 17:00–18:30; principal scientific symposia start at 09:00 on 26–28 October. The closing plenary is 28 October, 16:15–17:30, followed by a reception until 18:30. Times are America/Chicago, CDT (UTC−05:00). Current full-conference fees are US$1,705 for members, US$2,145 for non-members and US$325 for student/postdoc members; one-day passes are available. Registration requires an AAPS portal account. Use the official registration page linked from the event website. Ordinary cancellation refunds are no longer available.

The congress connects experimental and clinical pharmacology, from identifying therapeutic targets and testing mechanisms in preclinical models to clinical trials, access to treatment and evidence from routine care. Its programme examines synaptic and cellular communication in neurodegeneration, immunometabolism, inflammation, oncology, precision medicine and sex-aware experimental design. Sessions also address drug development, regulatory decisions, artificial intelligence and the sustainability of pharmacological research. Plenary lectures connect unmet needs in oncology to improved care and trace lysosomal calcium signalling from discovery towards clinical applications. Parallel symposia, young-investigator presentations and discussions bring together basic research and translational practice. Times are Europe/Rome (CET, UTC+1). On 25 November, parallel sessions begin at 13:30, the opening ceremony is 15:30–16:00 and the first plenary is 16:00–17:00. Morning sessions begin at 08:30 on 26–28 November. The final plenary is 11:30–12:30 on 28 November, followed by conclusions and awards until 13:00. Standard full-congress fees are EUR 500 for SIF members and EUR 300 for members under 38; academic non-members pay EUR 854, or EUR 488 if under 38, including VAT. Industry non-members pay EUR 1,159, with a higher PayPal rate. Day tickets are available. Shared-room accommodation for eligible non-tenured SIF members under 38 is subject to a waiting list after 16 June. Registration requires a separate congress-platform account; SIF website credentials do not apply.

A Keystone Symposium connecting genetics, functional genomics, developmental neurobiology, and industry to identify convergent mechanisms and therapeutic opportunities in neurodevelopmental disorders.

This Keystone Symposium examines how nerves and neural activity shape cancer initiation, progression, metastasis, cognition, and treatment, with a focus on actionable therapeutic targets.